Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | FABP4 | P15090 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | QPCT | Q16769 | 1/20 | 0.37 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.37 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25091028 | 0.85 | HTT (0.50) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL29008276 | 0.82 | HTT (0.47) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL5923834 | 0.80 | HTT (0.53) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL11979603 | 0.80 | HTT (0.48) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL27884358 | 0.77 | HTT (0.46) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL187487 | 0.76 | — | — | |
| SCHEMBL6300741 | 0.75 | HTT (0.58) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL1157477 | 0.75 | HTT (0.58) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL2089384 | 0.75 | HTT (0.44) | HTTTP53TSHRMEN1KMT2A | |
| SCHEMBL25091130 | 0.75 | HTT (0.44) | HTTTP53TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101362755-B | Sulfosulfuron preparation method | JIANGSU AGROCHEM LAB | 2012-01-11 | — | — | CN | claimed |
| CN-101362755-A | Sulfosulfuron preparation method | JIANGSU AGRICULTURAL HORMONE E (CN) | 2009-02-11 | — | — | CN | claimed |
| EP-3883037-B1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2023-03-01 | — | — | EP | disclosed |
| EP-4136086-A1 | TRICYCLIC PESTICIDAL COMPOUNDS | BASF SE (DE) | 2023-02-22 | — | — | EP | disclosed |
| EP-4061815-A1 | PYRIMIDONE DERIVATIVES CONTAINING TWO FUSED BICYCLIC RINGS | BASF SE (DE) | 2022-09-28 | — | — | EP | disclosed |
| WO-2016172631-A2 | SUBSTRATE SELECTIVE INHIBITORS OF INSULIN-DEGRADING ENZYME (IDE) AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-10-27 | — | — | WO | disclosed |
| CN-101230113-B | Sulfonyl grafted heterocycle materials for proton conducting electrolytes | TOYOTA MOTOR ENGINERING & MFG NORTH AMERICA INC | 2013-05-22 | — | — | CN | disclosed |
| US-8263563-B2 | Furin inhibitors | Smith, Robert E. (US) | 2012-09-11 | — | — | US | disclosed |
| US-8263563-B2 | Furin inhibitors | Smith, Robert E. (US) | 2012-09-11 | — | — | US | disclosed |
| US-8188284-B2 | 2-aminoquinolines | HOFFMAN-LA ROCHE INC. (US) | 2012-05-29 | — | — | US | disclosed |
| CN-101362755-B | Sulfosulfuron preparation method | JIANGSU AGROCHEM LAB | 2012-01-11 | — | — | CN | disclosed |
| US-20090171003-A1 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090131328-A1 | FURIN INHIBITORS | SMITH ROBERT E | 2009-05-21 | — | — | US | disclosed |
| US-20090131328-A1 | FURIN INHIBITORS | SMITH ROBERT E | 2009-05-21 | — | — | US | disclosed |
| US-7524900-B2 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2009-04-28 | — | — | US | disclosed |
| CN-101362755-A | Sulfosulfuron preparation method | JIANGSU AGRICULTURAL HORMONE E (CN) | 2009-02-11 | — | — | CN | disclosed |
| CN-101230113-A | Sulfonyl grafted heterocycle materials for proton conducting electrolytes | TOYOTA MOTOR ENGINERING & MFG (US) | 2008-07-30 | — | — | CN | disclosed |
| US-20080152985-A1 | SULFONYL GRAFTED HETEROCYCLE MATERIALS FOR PROTON CONDUCTING ELECTROLYTES | Toyota Engineering & Manufacturing North America, Inc. (US) | 2008-06-26 | — | — | US | disclosed |
| EP-1894971-A1 | GAS BARRIER COMPOSITION, COATING FILM, METHODS FOR PRODUCING THOSE, AND MULTILAYER BODY | Mitsui Chemicals, Inc. (JP) | 2008-03-05 | — | — | EP | disclosed |
| US-20060293448-A1 | Gas-barrier composition, coating film and method for production of the same, and layered material | MITSUI CHEMICALS, INC. (JP) | 2006-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131328-A1 | FURIN INHIBITORS | FURIN, PREP, TMPRSS15 | HTT 3952/4885TP53 592/4885TSHR 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.